MARCH 2024 NEUROENDOCRINE CANCER UK QUARTERLY NEWSLETTER

ADVANCING NEUROENDO AN UPDATE Research is fundamentally important as a means of providing a better unders are very proud to be using our Advancing Research campaign to have a mea raise funds for NC research to support those with the condition both today an their generous donations. Thank you so much for your support, we really app

NEUROENDOCRINE CANCER S

This is a new role in partnership with the Royal neuroendocrine cancer before, so we are very e neuroendocrine cancer among the wider surgica We are absolutely delighted to announce that M been appointed as the first neuroendocrine can Society and is based at University Hospital, Birm The SSL is a 3 year role, its aim is to establish t

The primary goals of Mr Ford’s research will focus on understanding the valu growing and when advanced, people can live a relatively long time. Surgery a major operation and could expose patients to harm with little benefit. Patien is uncertain if patients would be willing to be randomised (allocated by chanc patients. Mr Ford has said “I am absolutely delighted to have been appointed as the S investment for Neuroendocrine Cancer UK and I am very grateful for the tirel without which this role would not have been possible. I will use my time in po improve the quality and length of life for people living with NETs.” We look for community. CLICK HERE to listen to Lisa and Sam on episode 9 of the ‘Not Just NE Can world of surgical research in neuroendocrine cancer, what surgical research importance in advancing our understanding of this rare cancer and much mo

Made with FlippingBook flipbook maker